Clinical evaluation of the Capronor contraceptive implant: preliminary report

American Journal of Obstetrics and Gynecology
P D DarneyA Alvarado

Abstract

Capronor, a single-capsule, biodegradable, subdermal contraceptive that releases levonorgestrel over a 12- to 18-month period, has been evaluated in 48 healthy women, ages 18 to 40 years. Sixteen participants received a 2.5 cm capsule (12 mg of levonorgestrel), and 32 received a 4.0 cm capsule (21.6 mg of levonorgestrel). Serum levonorgestrel levels were significantly lower in the 2.5 cm group. Ovulation occurred in all cycles in the 2.5 cm group and in 26.3% of cycles in the 4.0 cm group. Levonorgestrel levels with the shorter capsule were too low for reliable contraception in all users, and 4 cm may be a minimal functional length. Bleeding patterns were regular in most women who ovulated and irregular in most remaining subjects. It is assumed that changes in cervical mucus and the endometrium contributed to effective contraception despite the frequency of ovulation.

References

Apr 1, 1984·American Journal of Obstetrics and Gynecology·S RoyM J Duda
Apr 14, 1983·The New England Journal of Medicine·P WahlB Rifkind

❮ Previous
Next ❯

Citations

Jan 10, 2009·Journal of Materials Science. Materials in Medicine·Mingzhu Sun, Sandra Downes
Aug 13, 2015·Journal of Functional Biomaterials·Darren J Lee
Jan 7, 1999·Drug Development and Industrial Pharmacy·V R Sinha, L Khosla
Jun 4, 2004·Expert Opinion on Biological Therapy·Antonio R WebbGuillermo A Ameer
May 1, 1994·American Journal of Obstetrics and Gynecology·P D Darney
Dec 11, 2007·International Journal of Pharmaceutics·P FerreiraM H Gil
Dec 17, 2014·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Dongxu KeSusmita Bose
Oct 20, 2015·Materials Science & Engineering. C, Materials for Biological Applications·José A PeñaLeón D Pérez
May 24, 2012·Journal of Biomedical Materials Research. Part a·Xian Jun LohFu Siong Chia
Sep 30, 2014·Clinical Oral Implants Research·Bee Tin GohSwee Hin Teoh
Oct 4, 2005·Biomaterials·Hongfan SunPengyan Wang
Nov 27, 2014·Journal of Biomedical Materials Research. Part a·J IdaszekW Święszkowski
Jan 31, 2014·Biomaterials·Jan J RongenPieter Buma
Jun 1, 2017·Biotechnology Advances·Sheva NaahidiP Chen
Jun 1, 2010·Journal of Biomaterials Applications·Anand P KhandwekarMukesh Doble
Jul 20, 2011·Journal of Polymer Science. Part B, Polymer Physics·Bret D UleryCato T Laurencin
Apr 19, 2008·Journal of Biomaterials Science. Polymer Edition·Z C C ChenD W Hutmacher
Nov 11, 2006·Journal of Biomaterials Science. Polymer Edition·Vinoy ThomasYogesh K Vohra
Jun 26, 2007·Journal of Materials Science. Materials in Medicine·P FerreiraM H Gil
Mar 1, 1992·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·X F LiJ Newton
Sep 23, 2008·Expert Review of Medical Devices·Giuseppe BenagianoManuela Farris
Nov 2, 2019·Journal of Tissue Engineering and Regenerative Medicine·Elmar WillboldJanin Reifenrath
Mar 1, 2017·Biofabrication·Almoatazbellah YoussefPaul D Dalton
Apr 25, 2020·Polymers·Liangpeng Ge, Shixuan Chen
Feb 9, 2020·International Journal of Molecular Sciences·Janin ReifenrathElmar Willbold
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jonathan FieldFrederik Claeyssens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.